07:53:58 EDT Sun 25 Sep 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:AEZS from 2021-09-24 to 2022-09-23 - 29 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2022-08-29 09:31C:AEZSAeterna Zentaris Inc (4)6.63News ReleaseAeterna to regain full rights to macimorelin from Novo
2022-08-03 19:14C:AEZSAeterna Zentaris Inc (4)6.335SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2022-08-03 19:14C:AEZSAeterna Zentaris Inc (4)6.335SEDAR MD & ASEDAR MD & A
2022-08-03 18:59C:AEZSAeterna Zentaris Inc (4)6.335News ReleaseAeterna loses $4.2-million (U.S.) in Q2
2022-07-19 20:10C:AEZSAeterna Zentaris Inc (3)0.265RollbackAeterna Zentaris 1:25 share rollback
2022-07-18 17:14C:AEZSAeterna Zentaris Inc (3)0.28News ReleaseAeterna's 1:25 share rollback to take effect July 21
2022-07-15 16:29C:AEZSAeterna Zentaris Inc (3)0.295News ReleaseAeterna receives shareholder OK for 1:25 share rollback
2022-07-06 16:49C:AEZSAeterna Zentaris Inc (3)0.26News ReleaseAeterna further adjourns meeting, hopes for rollback OK
2022-06-21 16:58C:AEZSAeterna Zentaris Inc (3)0.23News ReleaseAeterna Zentaris adjourns meeting to seek rollback OK
2022-06-13 12:14C:AEZSAeterna Zentaris Inc (3)0.25News ReleaseAeterna reaches proof of concept for NMOSD program
2022-05-25 16:41C:AEZSAeterna Zentaris Inc (3)0.26News ReleaseAeterna partner Consilient releases Ghryvelin in Europe
2022-05-16 13:11C:AEZSAeterna Zentaris Inc (3)0.25News ReleaseAeterna to hold AGM June 21, proposes share rollback
2022-05-11 12:48C:AEZSAeterna Zentaris Inc (3)0.295News ReleaseAeterna losses rise to $2.6-million (U.S.) in Q1 2022
2022-05-10 21:26C:AEZSAeterna Zentaris Inc (3)0.295SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2022-05-10 21:26C:AEZSAeterna Zentaris Inc (3)0.295SEDAR MD & ASEDAR MD & A
2022-04-19 12:43C:AEZSAeterna Zentaris Inc (3)0.41News ReleaseAeterna receives European patent for macimorelin
2022-03-29 11:44C:AEZSAeterna Zentaris Inc (3)0.455News ReleaseAeterna Zentaris loses $8.4-million in 2021
2022-03-28 22:45C:AEZSAeterna Zentaris Inc (3)0.465SEDAR MD & ASEDAR MD & A
2022-03-28 22:44C:AEZSAeterna Zentaris Inc (3)0.465SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2022-03-28 22:36C:AEZSAeterna Zentaris Inc (3)0.465SEDAR Annual ReportSEDAR Annual Report
2022-03-21 11:55C:AEZSAeterna Zentaris Inc (3)0.435News ReleaseAeterna halts Detect study enrolment in Ukraine, Russia
2022-03-10 12:07C:AEZSAeterna Zentaris Inc (3)0.44News ReleaseAeterna Zentaris increases scope of vaccine studies
2022-03-02 11:54C:AEZSAeterna Zentaris Inc (3)0.44News ReleaseAeterna Zentaris licensor receives patent allowance
2022-01-26 16:19C:AEZSAeterna Zentaris Inc (3)0.45News ReleaseAeterna has 180 more days to cure Nasdaq non-compliance
2022-01-26 11:44C:AEZSAeterna Zentaris Inc (3)News ReleaseAeterna reviews recent activities and next steps
2021-12-23 16:19C:AEZSAeterna Zentaris Inc (3)0.55News ReleaseAeterna Zentaris appoints La Fratta as senior VP, CFO
2021-11-04 17:41C:AEZSAeterna Zentaris Inc (3)0.82SEDAR MD & ASEDAR MD & A
2021-11-04 17:32C:AEZSAeterna Zentaris Inc (3)0.82News ReleaseAeterna Zentaris loses $1.7-million in Q3 2021
2021-11-04 17:32C:AEZSAeterna Zentaris Inc (3)0.82SEDAR Interim Financial StatementsSEDAR Interim Financial Statements